706 related articles for article (PubMed ID: 20494257)
1. Carrier screening for cystic fibrosis.
Dungan JS
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):47-59, Table of Contents. PubMed ID: 20494257
[TBL] [Abstract][Full Text] [Related]
2. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
[TBL] [Abstract][Full Text] [Related]
3. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.
Massie J; Forbes R; Dusart D; Bankier A; Delatycki MB
J Paediatr Child Health; 2007 Nov; 43(11):721-3. PubMed ID: 17924936
[TBL] [Abstract][Full Text] [Related]
4. An update on cystic fibrosis screening.
Goetzinger KR; Cahill AG
Clin Lab Med; 2010 Sep; 30(3):533-43. PubMed ID: 20638569
[TBL] [Abstract][Full Text] [Related]
5. A 10-year large-scale cystic fibrosis carrier screening in the Italian population.
Picci L; Cameran M; Marangon O; Marzenta D; Ferrari S; Frigo AC; Scarpa M
J Cyst Fibros; 2010 Jan; 9(1):29-35. PubMed ID: 19897426
[TBL] [Abstract][Full Text] [Related]
6. Newborn screening and carrier screening for cystic fibrosis: alternative or complementary?
Castellani C; Massie J
Eur Respir J; 2014 Jan; 43(1):20-3. PubMed ID: 24381320
[No Abstract] [Full Text] [Related]
7. Introduction to molecular cystic fibrosis testing.
Uphoff TS; Highsmith WE
Clin Lab Sci; 2006; 19(1):24-31. PubMed ID: 16617555
[TBL] [Abstract][Full Text] [Related]
8. Applying CFTR molecular genetics to facilitate the diagnosis of cystic fibrosis through screening.
Bobadilla JL; Farrell MH; Farrell PM
Adv Pediatr; 2002; 49():131-90. PubMed ID: 12214770
[No Abstract] [Full Text] [Related]
9. Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience.
Massie J; Petrou V; Forbes R; Curnow L; Ioannou L; Dusart D; Bankier A; Delatycki M
Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):484-9. PubMed ID: 19780730
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis screening.
Shulman LP
J Midwifery Womens Health; 2005; 50(3):205-10. PubMed ID: 15894998
[TBL] [Abstract][Full Text] [Related]
11. Prenatal screening for cystic fibrosis: where are we now?
Farrell PM; Fost N
J Pediatr; 2002 Dec; 141(6):758-63. PubMed ID: 12461490
[No Abstract] [Full Text] [Related]
12. [Cystic fibrosis: the CFTR gene, its mutations, the genetic counseling].
Goossens M; Ghanem N; Girodon E; Costes B; Fanen P
Rev Pneumol Clin; 1995; 51(3):130-6. PubMed ID: 7569574
[TBL] [Abstract][Full Text] [Related]
13. Sweat chloride testing in infants identified as heterozygote carriers by newborn screening.
Soultan ZN; Foster MM; Newman NB; Anbar RD
J Pediatr; 2008 Dec; 153(6):857-9. PubMed ID: 19014821
[TBL] [Abstract][Full Text] [Related]
14. [Genetic counseling in cystic fibrosis].
Julia S; Bieth E
Rev Mal Respir; 2000 Aug; 17(3 Pt 2):807-11. PubMed ID: 11076391
[TBL] [Abstract][Full Text] [Related]
15. The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening.
Thauvin-Robinet C; Munck A; Huet F; Génin E; Bellis G; Gautier E; Audrézet MP; Férec C; Lalau G; Georges MD; Claustres M; Bienvenu T; Gérard B; Boisseau P; Cabet-Bey F; Feldmann D; Clavel C; Bieth E; Iron A; Simon-Bouy B; Costa C; Medina R; Leclerc J; Hubert D; Nové-Josserand R; Sermet-Gaudelus I; Rault G; Flori J; Leroy S; Wizla N; Bellon G; Haloun A; Perez-Martin S; d'Acremont G; Corvol H; Clément A; Houssin E; Binquet C; Bonithon-Kopp C; Alberti-Boulmé C; Morris MA; Faivre L; Goossens M; Roussey M; ; Girodon E
J Med Genet; 2009 Nov; 46(11):752-8. PubMed ID: 19880712
[TBL] [Abstract][Full Text] [Related]
16. Cystic fibrosis mutations with widely variable phenotype: the D1152H example.
Mussaffi H; Prais D; Mei-Zahav M; Blau H
Pediatr Pulmonol; 2006 Mar; 41(3):250-4. PubMed ID: 16429425
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?
Scotet V; Audrézet MP; Roussey M; Rault G; Dirou-Prigent A; Journel H; Moisan-Petit V; Storni V; Férec C
Pediatrics; 2006 Nov; 118(5):e1523-9. PubMed ID: 17015492
[TBL] [Abstract][Full Text] [Related]
18. CFTR DeltaF508 mutation detection from dried blood samples in the first trimester of pregnancy: a possible routine prenatal screening strategy for cystic fibrosis?
Konialis CP; Hagnefelt B; Kazamia C; Karapanou S; Pangalos C
Fetal Diagn Ther; 2007; 22(1):41-4. PubMed ID: 17003555
[TBL] [Abstract][Full Text] [Related]
19. Screening for mutations in the cystic fibrosis transmembrane regulator gene in an infertility clinic.
Slostad J; Stein QP; Flanagan JD; Hansen KA
Fertil Steril; 2007 Dec; 88(6):1687-8. PubMed ID: 17482604
[TBL] [Abstract][Full Text] [Related]
20. Screening practices for mutations in the CFTR gene ABCC7.
Girodon-Boulandet E; Cazeneuve C; Goossens M
Hum Mutat; 2000; 15(2):135-49. PubMed ID: 10649490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
